Pulse Biosciences, Inc.
53.02USD
+0.3400 (+0.65%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on PLSE.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.29▼ | -$0.29 | 0 | 1 |
| Next quarter | -$0.3▼ | -$0.28 | 0 | 1 |
| Current year | -$1.11▼ | -$1.07 | 1 | 0 |
| Next year | -$1.17▼ | -$1.09 | 1 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.29 | -$0.28 | +0.00 (+1.5%) |
| 2026-03-31 | -$0.22 | -$0.24 | -0.02 (-9.7%) |
| 2025-12-31 | -$0.21 | -$0.18 | +0.03 (+14.3%) |
| 2025-09-30 | -$0.31 | -$0.29 | +0.02 (+6.5%) |
20 ratings from 8 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Oppenheimer | Maintained | Outperform | $35 $60 | Oct 13, 2026 |
| Canaccord Genuity | Maintained | Buy | $43 $58 | Oct 6, 2026 |
| BTIG | Initiated | Buy | $70 | Sep 23, 2026 |
| Freedom Capital Markets | Initiated | Buy | $73 | Sep 9, 2026 |
| Needham | Initiated | Buy | $58 | Aug 17, 2026 |
| Canaccord Genuity | Maintained | Buy | $32 $43 | Aug 10, 2026 |
| Canaccord Genuity | Initiated | Buy | $32 | Jun 4, 2026 |
| Oppenheimer | Initiated | Outperform | $22 | Jul 7, 2025 |
| Maxim Group | Downgraded from Buy | Hold | — | Sep 21, 2022 |
| HC Wainwright & Co. | Downgraded from Buy | Neutral | — | May 13, 2022 |
| Stephens & Co. | Maintained | Overweight | $14 $12 | Apr 1, 2022 |
| HC Wainwright & Co. | Maintained | Buy | $20 $8.5 | Apr 1, 2022 |
| HC Wainwright & Co. | Maintained | Buy | $43 $20 | Feb 10, 2022 |
| HC Wainwright & Co. | Maintained | Buy | $46 $43 | Nov 16, 2021 |
| Stephens & Co. | Initiated | Overweight | $28 | Jul 27, 2021 |
| Maxim Group | Initiated | Buy | $40 | Mar 11, 2021 |
| HC Wainwright & Co. | Maintained | Buy | $16 $40 | Jan 26, 2021 |
| HC Wainwright & Co. | Upgraded from Neutral | Buy | $6 $16 | May 12, 2020 |
| HC Wainwright & Co. | Downgraded from Buy | Neutral | $6 | Feb 14, 2020 |
| HC Wainwright & Co. | Initiated | Buy | — | Feb 25, 2019 |
25 filings from 7 insiders · 0 buy / 0 sell over 6m
Officers and directors of PLSE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| LAVIOLETTE PAUL AChief Executive Officer | Buy | 15.0k | $19.69 | $295k | May 11, 2026 |
| DUGGAN ROBERT WILLIAMDirector and Beneficial Owner of more than 10% of a Class of Security | Buy | 660.2k | $19.69 | $13.00M | May 11, 2026 |
| DANAHY KEVIN PATRICKOfficer | Sell | 5.0k | $23.64 | $118k | Feb 18, 2026 |
| DANAHY KEVIN PATRICKOfficer | Exercise | 5.0k | $1.53 | $8k | Feb 18, 2026 |
| DANAHY KEVIN PATRICKOfficer | Sell | 60.0k | $23.37 | $1.41M | Feb 17, 2026 |
| DANAHY KEVIN PATRICKOfficer | Exercise | 60.0k | $1.53 | $92k | Feb 17, 2026 |
| DANAHY KEVIN PATRICKOfficer | Sell | 60.0k | $21.45 | $1.40M | Feb 11, 2026 |
| DANAHY KEVIN PATRICKOfficer | Exercise | 60.0k | $1.53 | $92k | Feb 11, 2026 |
| DANAHY KEVIN PATRICKOfficer | Sell | 4.6k | $18.53 | $85k | Oct 2, 2025 |
| DANAHY KEVIN PATRICKOfficer | Exercise | 4.6k | $1.53 | $7k | Oct 2, 2025 |
| DANAHY KEVIN PATRICKOfficer | Sell | 20.4k | $18.48 | $377k | Sep 19, 2025 |
| DANAHY KEVIN PATRICKOfficer | Exercise | 20.4k | $1.53 | $31k | Sep 19, 2025 |
| UECKER DARRIN RChief Technology Officer | Sell | 45.0k | $16.21 | $731k | Sep 17, 2025 |
| UECKER DARRIN RChief Technology Officer | Exercise | 206.5k | $4.00 | $826k | Sep 17, 2025 |
| UECKER DARRIN RChief Technology Officer | Sell | 75.0k | $14.32 | $1.12M | Sep 15, 2025 |
| UECKER DARRIN RChief Technology Officer | Exercise | 75.0k | $4.00 | $300k | Sep 15, 2025 |
| DUGGAN ROBERT WILLIAMDirector and Beneficial Owner of more than 10% of a Class of Security | Buy | 192.6k | $14.66 | $3.44M | Sep 10, 2025 |
| UECKER DARRIN RChief Technology Officer | Sell | 30.0k | $15.98 | $486k | Jun 13, 2025 |
| ZANGANEH MAHKAMDirector | Exercise | 60.2k | $11.00 | $663k | Feb 3, 2025 |
| DUGGAN ROBERT WILLIAMDirector and Beneficial Owner of more than 10% of a Class of Security | Exercise | 5.31M | $11.00 | $58.37M | Dec 18, 2024 |
No analyst notes on PLSE yet.
Members whose judged calls on PLSE have played out most reliably.
No settled calls on PLSE yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
6 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 5 | 0 | 0 | 0 | Buy1.83 |
| 1 mo ago | 1 | 5 | 0 | 0 | 0 | Buy1.83 |
| 2 mo ago | 1 | 3 | 0 | 0 | 0 | Buy1.75 |
| 3 mo ago | 0 | 3 | 0 | 0 | 0 | Buy2.00 |